VANI
Vivani Medical, Inc.
1W: -6.1%
1M: -15.0%
3M: -21.2%
YTD: -15.0%
1Y: -1.8%
3Y: +16.1%
5Y: -97.5%
$1.02
-0.06 (-5.39%)
After Hours: $1.04 (+0.01, +1.45%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$63.8M
52W Range0.905-1.92
Volume269,759
Avg Volume319,669
Beta3.36
Dividend—
Analyst Ratings
Company Info
CEOAdam Mendelsohn
Employees37
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-11-19
Websitevivani.com
5858 Horton Street
Alameda, CA 94608
US
Alameda, CA 94608
US
818 833 5000
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Latest News
Vivani Medical GAAP EPS of -$0.43 misses by $0.01
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update
Vivani Medical, Inc. Announces Closing of Common Stock Offering
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Williams Gregg | P-Purchase | 1,310,680 | $1.03 | 2026-03-15 |
| Williams Gregg | P-Purchase | 264,551 | $1.26 | 2026-03-15 |
| Williams Gregg | P-Purchase | 1,601,941 | $1.03 | 2026-02-15 |
| Williams Gregg | P-Purchase | 264,551 | $1.26 | 2026-02-15 |
| Williams Gregg | P-Purchase | 1,351,351 | $1.48 | 2026-01-27 |